101 related articles for article (PubMed ID: 15299880)
1. Structure of monomeric porcine DesB1-B2 despentapeptide (B26-B30) insulin at 1.65 A resolution.
Diao JS; Wan ZL; Chang WR; Liang DC
Acta Crystallogr D Biol Crystallogr; 1997 Sep; 53(Pt 5):507-12. PubMed ID: 15299880
[TBL] [Abstract][Full Text] [Related]
2. Molecular replacement studies on crystal structure of DesB1-B2 Despentapeptide (B26-B30) insulin.
Diao J; Wan Z; Chang W; Liang D
Sci China C Life Sci; 1997 Oct; 40(5):524-30. PubMed ID: 20229305
[TBL] [Abstract][Full Text] [Related]
3. I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin.
Whittingham JL; Youshang Z; Záková L; Dodson EJ; Turkenburg JP; Brange J; Dodson GG
Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):505-11. PubMed ID: 16627943
[TBL] [Abstract][Full Text] [Related]
4. Molecular close-packing method and its application to crystal structure determination of deshexapeptide (B25-B30) insulin.
Ren Z; Liang DC
Sci China B; 1992 Jul; 35(7):783-90. PubMed ID: 1449604
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer.
Zoete V; Meuwly M; Karplus M
J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246
[TBL] [Abstract][Full Text] [Related]
6. The solution structure of a monomeric insulin. A two-dimensional 1H-NMR study of des-(B26-B30)-insulin in combination with distance geometry and restrained molecular dynamics.
Knegtel RM; Boelens R; Ganadu ML; Kaptein R
Eur J Biochem; 1991 Dec; 202(2):447-58. PubMed ID: 1761045
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of deshexapeptide (B25-B30) insulin at 0.25 nm resolution.
Chang W; Jiang T; Ren Z; Wan Z; Xu Y; Liang D; Zhu S; Zhang Y
Sci China B; 1995 Sep; 38(9):1094-100. PubMed ID: 8554678
[TBL] [Abstract][Full Text] [Related]
8. An insulin with the native sequence but virtually no activity.
Wollmer A; Gilge G; Brandenburg D; Gattner HG
Biol Chem Hoppe Seyler; 1994 Mar; 375(3):219-22. PubMed ID: 8011179
[TBL] [Abstract][Full Text] [Related]
9. Structural studies on des-pentapeptide (B26-30)-insulin. III. State of aggregation, tyrosyl environment, and peptide backbone conformation in solution.
Sci Sin; 1976; 19(4):475-85. PubMed ID: 10622
[TBL] [Abstract][Full Text] [Related]
10. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant.
Záková L; Brynda J; Au-Alvarez O; Dodson EJ; Dodson GG; Whittingham JL; Brzozowski AM
Biochemistry; 2004 Dec; 43(51):16293-300. PubMed ID: 15610023
[TBL] [Abstract][Full Text] [Related]
11. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor.
Kurose T; Pashmforoush M; Yoshimasa Y; Carroll R; Schwartz GP; Burke GT; Katsoyannis PG; Steiner DF
J Biol Chem; 1994 Nov; 269(46):29190-7. PubMed ID: 7961885
[TBL] [Abstract][Full Text] [Related]
12. Structure of an insulin dimer in an orthorhombic crystal: the structure analysis of a human insulin mutant (B9 Ser-->Glu).
Yao ZP; Zeng ZH; Li HM; Zhang Y; Feng YM; Wang DC
Acta Crystallogr D Biol Crystallogr; 1999 Sep; 55(Pt 9):1524-32. PubMed ID: 10489447
[TBL] [Abstract][Full Text] [Related]
13. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of the B-chain beta-turn in [GlyB24] insulin mutants: a steady-state fluorescence anisotropy study.
Pittman I; Nakagawa SH; Tager HS; Steiner DF
Biochemistry; 1997 Mar; 36(12):3430-7. PubMed ID: 9131992
[TBL] [Abstract][Full Text] [Related]
15. Studies on the crystal structure of (D-Ala)-B0 porcine insulin at 1.9 A resolution.
Niu LW; Dai JB; Liang DC
Sci China B; 1989 Apr; 32(4):419-34. PubMed ID: 2675905
[TBL] [Abstract][Full Text] [Related]
16. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
Nakagawa SH; Tager HS
J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
[TBL] [Abstract][Full Text] [Related]
17. The characteristics and motion model of insulin monomer.
Liang DC; Chang WR; Wang DC; Zhang JP
Sci China B; 1992 Apr; 35(4):418-28. PubMed ID: 1590917
[TBL] [Abstract][Full Text] [Related]
18. Structural studies on des-pentapeptide (B26-30)-insulin. IV. A preliminary investigation on the hydrophobic region by employing a fluorescence probe, 1-p-toluidinylnaphthalene-8-sulphonate.
Sci Sin; 1976; 19(4):486-96. PubMed ID: 10623
[TBL] [Abstract][Full Text] [Related]
19. FTIR studies of secondary structures of bovine insulin and its derivatives.
Wei JA; Lin YZ; Zhou JM; Tsou CL
Biochim Biophys Acta; 1991 Oct; 1080(1):29-33. PubMed ID: 1932079
[TBL] [Abstract][Full Text] [Related]
20. High resolution 1H-NMR studies of Des-(B26-B30)-insulin; assignment of resonances and properties of aromatic residues.
Hua QX; Chen YJ; Wang CC; Wang DC; Roberts GC
Biochim Biophys Acta; 1989 Feb; 994(2):114-20. PubMed ID: 2642711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
